» Articles » PMID: 35411090

Activated Src Requires Cadherin-11, Rac, and Gp130 for Stat3 Activation and Survival of Mouse Balb/c3T3 Fibroblasts

Overview
Date 2022 Apr 12
PMID 35411090
Authors
Affiliations
Soon will be listed here.
Abstract

We previously demonstrated that engagement of cadherins, cell to cell adhesion molecules, triggers a dramatic increase in levels and activity of the Rac/Cdc42 small GTPases, which is followed by secretion of IL6 family cytokines and activation of their common receptor, gp130, in an autocrine manner. This results in phosphorylation of the Signal Transducer and Activator of Transcription-3 (Stat3) on tyrosine-705, which then dimerizes, migrates to the nucleus, and activates transcription of genes involved in cell division and survival. In the present report we demonstrate that, in mouse Balb/c3T3 fibroblasts, mutationally activated Src also increases Rac levels, leading to secretion of IL6 family cytokines and gp130 activation, which triggers the Stat3-ptyr705 increase. Interestingly, our results also demonstrate that cadherin-11 is required to preserve gp130 levels for IL6 family signaling. At the same time, however, activated Src downregulates cadherin-11, in a quantitative manner. As a result, Src expression to intermediate levels allows sufficient cadherin-11, hence gp130 levels for Stat3 activation, as expected. However, expressed to high levels, Src eliminates cadherin-11, hence gp130 signaling, thus abolishing Stat3-ptyr705 stimulation. Taken together, these data establish for the first time a loop between Src, cadherin-11, gp130, and Stat3 activation. This fine balance between Src and cadherin-11 levels which is required for Stat3 activation and cellular survival could have significant therapeutic implications.

Citing Articles

Changes of Ex Vivo Cervical Epithelial Cells Due to Electroporation with JMY.

Halasz H, Szatmari Z, Kovacs K, Koppan M, Papp S, Szabo-Meleg E Int J Mol Sci. 2023; 24(23).

PMID: 38069185 PMC: 10706833. DOI: 10.3390/ijms242316863.


Roads to Stat3 Paved with Cadherins.

Adan H, Daniel J, Raptis L Cells. 2022; 11(16).

PMID: 36010614 PMC: 9406956. DOI: 10.3390/cells11162537.

References
1.
Ma J, Qin L, Li X . Role of STAT3 signaling pathway in breast cancer. Cell Commun Signal. 2020; 18(1):33. PMC: 7048131. DOI: 10.1186/s12964-020-0527-z. View

2.
Johnson D, OKeefe R, Grandis J . Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018; 15(4):234-248. PMC: 5858971. DOI: 10.1038/nrclinonc.2018.8. View

3.
Niu G, Wright K, Ma Y, Wright G, Huang M, Irby R . Role of Stat3 in regulating p53 expression and function. Mol Cell Biol. 2005; 25(17):7432-40. PMC: 1190305. DOI: 10.1128/MCB.25.17.7432-7440.2005. View

4.
Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M . Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006; 12(1):11-9. DOI: 10.1158/1078-0432.CCR-04-1752. View

5.
Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798-809. PMC: 4856025. DOI: 10.1038/nrc2734. View